PREPARATION AND CHARACTERIZATION OF THE RECOMBINANT NOROVIRUS VP1 SURFACE PROTEIN S DOMAIN



Cite item

Full Text

Abstract

Introduction. In the structure of the norovirus surface VP1, it consists of the S domain which N-terminal sequence is responsible for capsid formation, and P domain that extends beyond the capsid. Possibility of using S domain for preparing chimeric virus-like particles is shown.

The aim of the work is to obtain a recombinant VP1 protein S domain and to characterize its immunogenic and antigenic properties.

Materials and methods. Cloning of the sequence encoding VP1 protein S domain, modeling the structure of proteins, microbiological methods for working with E. coli cells producing recombinant proteins, polymerase chain reaction, electrophoresis of nucleic acids in an agarose gel and proteins in a polyacrylamide gel, affinity chromatography, enzyme immunoassay, electron microscopy were applied during the study.

Results. A genetic construct encoding the recombinant VP1 norovirus genotype GII.4 protein S domain optimized for highly efficient expression in E. coli is obtained. E. coli Rosetta 2 cells were transformed with the genetic construct. Conditions for protein production and purification were optimized. A soluble recombinant protein reproducing norovirus VP1 protein S domain and forming virus-like particles with a diameter of 30 nm is obtained. Immunization of mice with the obtained protein caused specific antibody production including low-avidity IgM antibodies. When assessing antigenic properties, it was shown that antibodies interacting with the recombinant S domain are found in the blood samples collected from volunteers. Antibody titers, but of lower avidity, specific to the latter corresponded to those against full-length VP1. Likely, it was due to the localization of the S domain inside the viral particle.

Conclusion. Antigenic and immunogenic properties of recombinant protein reproducing structure of norovirus VP1 S domain are characterized, and its ability to form virus-like particles is shown.

About the authors

Vladislav Alexandrovich Lapin

Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, Nizhny Novgorod, Russia

Email: fridens.95@yandex.ru
ORCID iD: 0000-0002-5905-5722
Scopus Author ID: 57201613755

Junior Researcher, Immune Chemistry Laboratory

Россия, 603950, Nizhniy Novgorod, Malaya Yamskaya str., 71

Dmitry Victorovich Novikov

Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, Nizhny Novgorod, Russia

Email: novikov.dv75@mail.ru
ORCID iD: 0000-0001-7049-6935
Scopus Author ID: 56471380300

PhD (Biology), Associate Professor, Leading Researcher, Immune Chemistry Laboratory

Россия, 603950, Nizhniy Novgorod, Malaya Yamskaya str., 71

Ekaterina V. Mokhonova

Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, Nizhny Novgorod, Russia

Email: ekaterinamohonova@yandex.ru
ORCID iD: 0000-0002-9742-7646

Researcher, Immune Chemistry Laboratory, I.N. Blokhina Nizhny Novgorod Scientific and Research Institute of Epidemiology and Microbiology of the Rospotrebnadzor

Россия, 603950, Nizhniy Novgorod, Malaya Yamskaya str., 71

Dmitry Alexandrovich Melentiev

Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, Nizhny Novgorod, Russia

Email: dim-melente@yandex.ru
ORCID iD: 0000-0002-2441-6874
Scopus Author ID: 57207916492

Junior Researcher, Immune Chemistry Laboratory

Россия, 603950, Nizhniy Novgorod, Malaya Yamskaya str., 71

Maria Igorevna Tsyganova

Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, Nizhny Novgorod, Russia

Email: maria_che@mail.ru
ORCID iD: 0000-0002-2811-6844
Scopus Author ID: 57207910339

Candidate of Biological Sciences, V.N.S. lab. Immunochemistry 

Россия, 603950, Nizhniy Novgorod, Malaya Yamskaya str., 71

Elvira Alexandrovna Manakova

TIAS LOTUS Limited Liability Company, Nizhny Novgorod, Russia

Email: fridens.95@yandex.ru
ORCID iD: 0000-0003-2317-2780

PhD (Medicine), Director of Medicine, Doctor of Clinical Laboratory Diagnostic

Россия, 603006, Nizhny Novgorod Region, Nizhny Novgorod, Belinsky Street, 110, room p3

Viktor Vladimirovich Novikov

Academician I.N. Blokhina Nizhny Novgorod Scientific Research Institute of Epidemiology and Microbiology, Nizhny Novgorod, Russia

Author for correspondence.
Email: mbre@mail.ru
ORCID iD: 0000-0002-2449-7213
Scopus Author ID: 7402005487

PhD, MD (Biology), Professor, Head of the Immune Chemistry Laboratory

Россия, 603950, Nizhniy Novgorod, Malaya Yamskaya str., 71

References

  1. Быков Р.О. , Скрябина С.В., Килячина А.С., Итани Т.М., Чалапа В.И., Старикова П.К., Колтунов С.В., Пономарева А.В., Семенов А.В. Молекулярно-генетическая характеристика и филогенетический анализ возбудителей норовирусной инфекции человека отдельных муниципалитетов в Свердловской области за 2022 год. Журнал микробиологии, эпидемиологии и иммунобиологии. 2023. Т.100, № 4. С. 306–313.
  2. Лапин В.А., Новиков Д.В., Мохонова Е.В., Мелентьев Д.А., Цыганова М.И., Зайцев Д.Е., Новиков В.В. Получение рекомбинантного белка VP1 норовируса и его антигенные и иммуногенные свойства. Журнал микробиологии, эпидемиологии и иммунобиологии. 2024. Т. 101, № 5. С. 661–667.
  3. Новиков Д. В., Мелентьев Д. А., Мохонов В. В., Кашников А. Ю., Новикова Н. А., Лапин В. А., Мохонова Е. В., Новиков В. В. Получение вирусоподобных частиц норовируса, содержащих VP1 эховируса 30. Вопросы вирусологии. 2021. Т. 66, №5. С.383–389.
  4. В.Ю. Талаев, Д.В. Новиков, И.Е. Заиченко, М.В. Светлова, Е.В. Воронина, О.Н. Бабайкина, В.А. Лапин, Д.А. Мелентьев, Н.А. Новикова, А.Ю. Кашников, В.В. Новиков Химерные вирусоподобные частицы, содержащие фрагмент белка шипа коронавируса, стимулируют созревание дендритных клеток человека. Инфекция и иммунитет. 2024. Т 14, №2. С. 227–237.
  5. Beek J., de Graaf M., Al-Hello H., et al. Molecular surveillance of norovirus, 2005–16: an epidemiological analysis of data collected from the NoroNet network. Lancet Infect. Dis. 2018, vol. 18, no. 5, pp. 545–553.
  6. Bertolotti-Ciarlet A., White L.J., Chen R., et al. Structural Requirements for the Assembly of Norwalk Virus-Like Particles. J Virol. 2002, vol. 76, pp. 4044–4055.
  7. Black R.E., Perin J., Yeung D., et al. Estimated global and regional causes of deaths from diarrhea in children younger than 5 years during 2000-21: a systematic review and Bayesian multinomial analysis. Lancet Glob. Health. 2024, vol. 12, no. 6, pp. 919–928.
  8. Fang H., Tan M., Xia M., et al. Norovirus P particle efficiently elicits innate, humoral and cellular immunity. PLoS ONE. 2013, vol. 8, no. 4, pp. 63269.
  9. Ford-Siltz L.A. Tohma K., Parra G.I. Understanding the relationship between norovirus diversity and immunity gut. Microbes. 2021, vol. 13, no. 1, pp. 1-13.
  10. Gulati U., Kumari K., Wu W., et al. Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination. Vaccine. 2005, vol. 23, no. 11, pp.1414-1425.
  11. Hasso-Agopsowicz M., Hwang A., Hollm-Delgado M.-G., et al. Identifying WHO global priority endemic pathogens for vaccine research and development (R&D) using multi-criteria decision analysis (MCDA): an objective of the Immunization Agenda 2030. EBioMedicine. 2024, vol. 110.
  12. Jeon K., Lee S.K., Jeong S., et al. Trends in the detection of viruses causing gastroenteritis over a 10-year period and impact of nonharmaceutical interventions. J. Clin. Virol. 2024, vol. 172, pp. 105676.
  13. Kanno A., Kazuyamal Y. Immunoglobulin G Antibody Avidity Assay for Serodiagnosis of Hepatitis C Virus Infection. Journal of Medical Virology. 2002, vol. 68, no. 2, pp. 229-33.
  14. Li X., Zhou R., Tian X. et al. Characterization of a cross-reactive monoclonal antibody against Norovirus genogroups I, II, III and V. Virus Res. 2010, vol. 151, no. 2, pp. 142-147.
  15. Ludwig-Begall L.F., Mauroy A., Thiry E. Noroviruses — The State of the Art, Nearly Fifty Years after Their Initial Discovery. Viruses. 2021, vol. 13, no. 8, pp. 1541.
  16. Parra G. I., Azure J., Fischer R. et al. Identification of a Broadly Cross-Reactive Epitope in the Inner Shell of the Norovirus Capsid. PLoS One. 2013, vol. 8, no. 6.
  17. Prasad B.V.V., Hardy M. E., et al. X-ray crystallographic structure of the Norwalk virus capsid. Science. 1999, vol. 286, pp. 287-290.
  18. Smith H.Q., Smith T.J. The Dynamic Capsid Structures of the Noroviruses. Viruses. 2019, vol. 11, no. 3, pp. 235.
  19. Xia M., Huang P., Sun C., et al. Bioengineered Norovirus S(60) Nanoparticles as a Multifunctional Vaccine Platform. ACS Nano. 2018, vol. 12, no. 11, pp. 10665-10682.
  20. Yoda T., Suzuki Y., Terano Y. et al. Precise Characterization of Norovirus (Norwalk-Like Virus)-Specific Monoclonal Antibodies with Broad Reactivity. J Clin Microbiol. 2003, vol. 41, no. 6, pp. 2367–2371.
  21. Zharova A.-M.D., Talayev V.Yu., Perenkov A.D., et al. In silico analysis of the antigenic properties of norovirus GII.4 Sydney [P16] VP1 proein. Opera Med.Physiol. 2023, vol. 10, no. 3, pp. 140-151.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Lapin V.A., Novikov D.V., Mokhonova E.V., Melentiev D.A., Tsyganova M.I., Manakova E.A., Novikov V.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies